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Abstract
Purpose: The purpose of this study was to evaluate the risk of recurrence of optic neuritis after corneal
refractive surgery in patients with a history of optic neuritis and to examine the safety and efﬁcacy of the
procedure in this population.
Methods: This was a retrospective chart review of patients with a history of optic neuritis who underwent
laser-assisted in situ keratomileusis (LASIK) or photorefractive keratectomy (PRK) at a single tertiary center
from June 1996 to December 2014. Fifteen eyes of 14 patients were included in this study. Visual acuity
before and after the surgery was recorded. Patients were followed-up for over ﬁve years postoperatively for
the recurrence of optic neuritis.
Results: The average LogMAR best corrected visual acuity (BCVA) preoperatively was 0.12 ± 0.19 (–0.10 to
0.60) and postoperatively was 0.06 ± 0.10 (–0.10 to 0.30). No eyes lost lines of BCVA. The average LogMAR
uncorrected distance visual acuity (UDVA) after surgery was 0.12 ± 0.13 (0.00 to 0.48). Twenty-eight percent
of patients reached a UDVA of 20/20 or better after refractive surgery. Optic neuritis recurred in 3/15 (20%)
eyes and 3/14 patients (21%).
Conclusion: While corneal refractive procedures appear safe in patients with a history of optic neuritis, our
data suggest that their efﬁcacy may be reduced.
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There are various potential causes of optic neuritis, including multiple sclerosis (MS), systemic
lupus erythematosus, antiphospholipid syndrome,
Sjogren’s syndrome, and multiple vasculitides.[1–4]
This is an open access journal, and articles are distributed under the terms of
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Optic neuritis is most commonly associated with
MS, with approximately 50% of patients experiencing an episode during their lifetime.[5] The
most common pathologic basis for optic neuritis is immune-mediated inﬂammatory demyelination of the optic nerve.[6] Previous research
has demonstrated disturbances during corneal
wound healing in various growth factors, cytokines,
and inﬂammatory cells commonly involved in the
pathophysiology of optic neuritis.[7] While various studies have evaluated outcomes of refractive procedures in patients with other autoimmune diseases, there is limited data on patients
with a previous history of optic neuritis.[8, 9] The
aim of this study was to determine the risk of
recurrence in patients with a previous history
of optic neuritis after corneal refractive surgery.
Additionally, we evaluated the safety and efﬁcacy of corneal refractive surgery in this population.

METHODS
This was a retrospective chart review of all
patients with a history of optic neuritis, who
underwent laser-assisted in situ keratomileusis
(LASIK) or photorefractive keratectomy (PRK)
at a single tertiary center from June 1996 to
December 2013. A single surgeon performed
all the procedures. At the time of surgery, the
patients had experienced their most recent
episode of optic neuritis at least two years
previously.
Patients included in this study underwent complete refractive surgery workup to rule out herpes,
keratoconus, posterior or anterior segment pathology, pars planitis, previous uveitis, or corneal ectasia. Preoperative review of systems was negative
for any MS-related symptoms, including bladder
dysfunction, motor or sensory disturbances, or
visual involvement.
Each patient received approval for LASIK or
PRK through consultation with a neurologist
and/or family physician who determined that there
was no active disease at the time of surgery.
All patients underwent standard preoperative
refractive workup including uncorrected distance
visual acuity (UDVA), best corrected distance
visual acuity (CDVA), manifest and cycloplegic
refractions, applanation tonometry, slit lamp

biomicroscopy,
indirect
ophthalmoscopy,
pachymetry, and corneal topography. Risks
and beneﬁts of the procedure were explained
to the patients, and all patients provided written
informed consent.
Twelve of the thirteen LASIK procedures
were performed using the VISX excimer laser
(Santa Clara, California, USA) with ablation
zones of 6–8 mm and ﬂap creation using the
Hansatome microkeratome (Bausch & Lomb,
Rochester, New York, USA). One procedure
was performed using a 400 Hz excimer laser
(Alcon, Fort Worth, Texas, USA) with ﬂap creation
performed using Alcon’s FS200 femtosecond
laser. There were no intraoperative complications.
Patients were routinely examined one day, one
week, and one, three, six, twelve, and twentyfour months after the surgery. Postoperatively,
patients received the standard pharmacological
regimen, which included one week of topical
prednisolone acetate 1% four times a day and
a third- or fourth-generation ﬂuoroquinolone
four times a day, as well as frequent doses of
preservative-free topical lubricants for several
months.
The PRK procedure consisted of scoring the
corneal epithelium using an 8.0-mm trephine
with alcohol-assisted epithelial debridement. Laser
ablation with a 6.0 mm optical zone and an 8mm blend was performed using a VISX excimer
laser. Patients then received a bandage contact lens with ﬂuoroquinolone and prednisolone
acetate 1% drops, each four times a day. After the
ﬁrst week, the bandage contact lens and antibiotic drops were discontinued, and prednisolone
acetate 1% was continued four times a day for
three additional weeks. Following this, the steroid
was changed to ﬂuorometholone 0.1%, whose dose
was tapered over the course of additional eight
weeks. Postoperative follow-up was performed
after one day, one week, and one, three, and six
months.
Patients were followed over ﬁve years postoperatively and data collected included time
from LASIK or PRK to the diagnosis of optic
neuritis and visual acuity. The recurrence of
optic neuritis was diagnosed clinically and conﬁrmed by direct visualization of a pale optic
nerve. In patients who developed recurrence postoperatively, the UDVA and CDVA before and
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after the episode were recorded. Visual acuity was converted to LogMAR as described by
Holladay.[10]

RESULTS
A total of 14 patients (15 eyes) underwent surgery.
PRK was performed on 4 eyes and LASIK was
performed on 11 eyes. Of the 15 eyes, 6 were
right and 9 were left. The ratio of female to
male patients was 11:3. The age of the patients
ranged from 23 to 55 years, with a mean age
of 34 years. Nine of the fourteen patients had
been previously diagnosed with MS. The cause
of optic neuritis was not known in the remaining
ﬁve patients. All eyes demonstrated optic nerve
pallor on preoperative funduscopic examination,
except one patient in whom no optic nerve pallor
was seen. Refractive errors corrected included one
hyperopic eye, two eyes with signiﬁcant astigmatic
error, and 12 myopic eyes ranging from –2.50 D to
–10.00 D [Table 1].
Postoperative refraction revealed 10 patients
(66.6%) with emmetropia and 4 (26.6%) with residual refractive error (+1.00 D to –2.13 D SEQ).
Visual acuity was measured in all patients within
six months postoperatively. The average LogMAR
UDVA after surgery was 0.12 ± 0.13 (0.00 to
0.48). Twenty-eight percent of patients reached a
UDVA of 20/20 or better after refractive surgery,
excluding the eye that was targeted for monovision
from the calculation [Figure 1]). The UDVA in all
patients was 20/40 or better, except in one patient
with monovision and in another with residual refractive error. Both the patients improved to 20/40
or better with correction. The average LogMAR
BCVA preoperatively was 0.12 ± 0.19 (—0.10 to
0.60) and postoperatively was 0.06 ± 0.10 (–0.10
to 0.30). No eye lost lines of CDVA. Ten patients
had no change in CDVA, two patients gained one
line, and three patients gained two lines [Figure
2].
Three of the 15 eyes (20%) experienced recurrence of optic neuritis postoperatively. The recurrence occurred in one patient three years after
PRK and two patients after LASIK at the fourth
and ﬁfth years, respectively. Each of these three
patients experienced persistent vision loss. CDVA
measured after resolution of acute optic neuritis
was 20/40 in two patients and 20/60 in the third
patient.
438

DISCUSSION
While various studies have examined the increased
risk of developing optic neuropathy after intraocular surgery, there is limited literature on the risk of
developing optic neuritis.[11, 12] Our study examined
patients with a history of optic neuritis in order to
determine recurrence rates, visual outcomes, and
safety of refractive surgery.
It is well established that optic neuritis typically
affects relatively young women. In this study,
11/14 patients (78.5%) were women, compared to
77.2% reported in the optic neuritis treatment trial
(ONTT).[5] In a retrospective chart review performed
at the Mayo Clinic, the mean age of patients with
optic neuritis was 31 years, which is marginally
lower than the mean age of our sample population
(34 years).[13] Of note, only two patients were over
40 years of age. Based on these demographics,
our study population appears to serve as an
appropriate sample of the general population of
patients with optic neuritis.
Interestingly, one patient in our sample had a
history of bilateral optic neuritis which is described
as being less prevalent than unilateral optic
neuritis.[14, 15] In the ONTT, out of the patients who
initially presented with unilateral optic neuritis, 9%
subsequently developed bilateral symptoms. Bilateral optic neuritis appears to have a good prognosis with recovery of vision if treated appropriately.[15]
Notably, our patient with bilateral optic neuritis did
not have recurrence and improved to a CDVA of
20/20 in both eyes after surgery.
Although, to the best of our knowledge, no studies have evaluated visual outcomes after refractive
surgery in patients with a history of optic neuritis,
Hashemi et al investigated visual outcomes in 15
eyes of eight patients with MS after LASIK.[16] Our
results are comparable with that reported in the
aforementioned study, as average postoperative
UDVA and CDVA were approximately 20/25 when
excluding the single eye that was targeted for
monovision based on calculation of UDVA. While
the percentage of patients in the general population with UDVA of 20/20 or better after LASIK
or PRK has been reported as 42– 48%, only 28%
of patients in our study reached this outcome.[17]
Thus, our study is consistent with previous reports
and suggests the safety of refractive procedures
in patients with a history of optic neuritis, but may
indicate decreased efﬁcacy.
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Table 1. Patients’ information.
Patient Eye

1

OD

Age

Sex

Nerve
Pallor

MS

Preop
BCVA

Surgery

Postop
UDVA

Postop
BCVA

34

Female

Y

Y

20/20

LASIK

20/20

20/20

Y

Y

20/20

LASIK

20/20

20/20

OS
2

OD

27

Female

Y

N

20/30

LASIK

20/30

20/25

3

OD

41

Female

Y

Y

20/25

PRK

20/25

20/25

4

OS

34

Male

Y

N

20/50

LASIK

20/30

20/30

5

OD

39

Male

Y

Y

20/30

LASIK

20/30

20/30

6

OS

33

Female

Y

Y

20/20

LASIK

20/20

20/20

7

OD

29

Female

Y

Y

20/25

LASIK

20/25

20/25

8

OS

29

Female

Y

Y

20/80

LASIK

20/60

20/40

9

OS

23

Female

Y

N

20/40

LASIK

20/30

20/25

10

OS

33

Male

Y

Y

20/20

PRK

20/20

20/20

11

OS

55

Female

N

N

20/15

PRK

20/80

20/15

12

OS

33

Female

Y

N

20/20

LASIK

20/25

20/20

13

OS

33

Female

Y

Y

20/20

PRK

20/25

20/20

14

OD

35

Female

Y

Y

20/25

LASIK

20/25

20/20

Recurrence

Time to BCVA Post
Recurrence
ON
Recovery

Yes

3 years

20/40

Yes

4 years

20/60

Yes

5 years

20/40

MS, multiple sclerosis; BCVA, best corrected visual acuity; LASIK, laser-assisted in situ keratomileusis; N, no; OD, right eye; OS,
left eye; PRK, photorefractive keratectomy; UDVA, uncorrected distance visual acuity; Y, yes; Postop, postoperative

Figure 1. Postoperative uncorrected distance visual acuity (UDVA). Cumulative UDVA at six months postoperatively.
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Figure 2. Change in best corrected visual acuity (BCVA). Change in BCVA preoperatively versus six months postoperatively.

Previous studies have reported an occurrence
of optic neuritis shortly after refractive surgery;
therefore, one of the aims of this study was to
evaluate the risk of recurrence of optic neuritis after
these procedures.[12] Of note, the ONTT offered
long-term follow-up of patients after an episode
of optic neuritis. After ﬁve years of follow-up, 30%
of patients had experienced recurrence of optic
neuritis, while our results showed recurrence after
refractive surgery in 30% of eyes.[18] Our data does
not show an increased risk of recurrence of optic
neuritis after refractive surgery compared to the
general population; however, subsequent studies
with larger sample sizes and inclusion of matched
controls are needed to adequately address this
comparison.
While most patients in our study had a history of
MS, ﬁve patients reported no history of conditions
associated with optic neuritis. The ONTT found that
patients who met the clinical criteria for optic neuritis carried a 50% risk of developing MS over a 15year follow-up period.[19] It remains unclear whether
optic neuritis in the ﬁve patients in our study was
due to a demyelinating process or another underlying disease yet to be identiﬁed. Further studies
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are needed to evaluate the outcomes of refractive
surgery and the risk of recurrence in patients with
non-demyelinating systemic conditions related to
optic neuritis.
In populations associated with increased risk of
recurrence of optic neuritis, it is important to consider measures of vision other than standard visual
acuity. Contrast sensitivity can be used to detect
deﬁcits in vision that would otherwise be missed
using a standard Snellen chart.[20] Optic neuritis is
a known risk factor for loss of contrast sensitivity,
with up to 78% of patients experiencing persistent impairment even after resolution of active
disease, regardless of recovery of visual acuity.[18]
Additionally, refractive surgery has been shown
to negatively impact contrast sensitivity.[21, 22] The
presence of both risk factors and the possible
compounding effects on visual outcomes warrants
further investigation.
Absolute and relative contraindications to refractive surgery have been suggested to optimize
patient outcomes and reduce postoperative complications. Although active, uncontrolled autoimmune diseases are considered absolute contraindications, studies have shown that patients with a
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variety of well-controlled diseases can safely and 6.
effectively undergo surgery.[8] Importantly, patients
in this study were only included if they met speciﬁc
criteria indicating control of disease. In order to 7.
achieve acceptable outcomes in patients with a
history of optic neuritis who wish to undergo refrac- 8.
tive surgery, clinicians must ensure appropriate
preoperative evaluation of patients. All patients
should receive surgical clearance by a neurologist
or physician with experience in the diagnosis 9.
and management of optic neuritis. Additionally, a
comprehensive informed consent should include
a discussion about the paucity of data available
regarding the impact of optic neuritis on efﬁcacy of 10.
surgery, recurrence of disease, and possible loss of
11.
contrast sensitivity.
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